116 related articles for article (PubMed ID: 11212150)
1. Disease-modifying activity of SB 273005, an orally active, nonpeptide alphavbeta3 (vitronectin receptor) antagonist, in rat adjuvant-induced arthritis.
Badger AM; Blake S; Kapadia R; Sarkar S; Levin J; Swift BA; Hoffman SJ; Stroup GB; Miller WH; Gowen M; Lark MW
Arthritis Rheum; 2001 Jan; 44(1):128-37. PubMed ID: 11212150
[TBL] [Abstract][Full Text] [Related]
2. Disease-modifying activity of SB 242235, a selective inhibitor of p38 mitogen-activated protein kinase, in rat adjuvant-induced arthritis.
Badger AM; Griswold DE; Kapadia R; Blake S; Swift BA; Hoffman SJ; Stroup GB; Webb E; Rieman DJ; Gowen M; Boehm JC; Adams JL; Lee JC
Arthritis Rheum; 2000 Jan; 43(1):175-83. PubMed ID: 10643714
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis.
Koufany M; Moulin D; Bianchi A; Muresan M; Sebillaud S; Netter P; Weryha G; Jouzeau JY
Arthritis Res Ther; 2008; 10(1):R6. PubMed ID: 18199331
[TBL] [Abstract][Full Text] [Related]
4. Kinetics of bone protection by recombinant osteoprotegerin therapy in Lewis rats with adjuvant arthritis.
Campagnuolo G; Bolon B; Feige U
Arthritis Rheum; 2002 Jul; 46(7):1926-36. PubMed ID: 12124878
[TBL] [Abstract][Full Text] [Related]
5. Idoxifene, a novel selective estrogen receptor modulator, is effective in a rat model of adjuvant-induced arthritis.
Badger AM; Blake SM; Dodds RA; Griswold DE; Swift BA; Rieman DJ; Stroup GB; Hoffman SJ; Gowen M
J Pharmacol Exp Ther; 1999 Dec; 291(3):1380-6. PubMed ID: 10565864
[TBL] [Abstract][Full Text] [Related]
6. IKKbeta inhibition protects against bone and cartilage destruction in a rat model of rheumatoid arthritis.
Schopf L; Savinainen A; Anderson K; Kujawa J; DuPont M; Silva M; Siebert E; Chandra S; Morgan J; Gangurde P; Wen D; Lane J; Xu Y; Hepperle M; Harriman G; Ocain T; Jaffee B
Arthritis Rheum; 2006 Oct; 54(10):3163-73. PubMed ID: 17009244
[TBL] [Abstract][Full Text] [Related]
7. Disease-modifying activity of SK&F 106615 in rat adjuvant-induced arthritis. Multiparameter analysis of disease magnetic resonance imaging and bone mineral density measurements.
Bradbeer JN; Kapadia RD; Sarkar SK; Zhao H; Stroup GB; Swift BA; Rieman DJ; Badger AM
Arthritis Rheum; 1996 Mar; 39(3):504-14. PubMed ID: 8607900
[TBL] [Abstract][Full Text] [Related]
8. NE-58095: a diphosphonate which prevents bone erosion and preserves joint architecture in experimental arthritis.
Francis MD; Hovancik K; Boyce RW
Int J Tissue React; 1989; 11(5):239-52. PubMed ID: 2517540
[TBL] [Abstract][Full Text] [Related]
9. Design and characterization of orally active Arg-Gly-Asp peptidomimetic vitronectin receptor antagonist SB 265123 for prevention of bone loss in osteoporosis.
Lark MW; Stroup GB; Hwang SM; James IE; Rieman DJ; Drake FH; Bradbeer JN; Mathur A; Erhard KF; Newlander KA; Ross ST; Salyers KL; Smith BR; Miller WH; Huffman WF; Gowen M
J Pharmacol Exp Ther; 1999 Nov; 291(2):612-7. PubMed ID: 10525079
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of FK506 and methotrexate on inflammatory cytokine levels in rat adjuvant-induced arthritis.
Magari K; Miyata S; Nishigaki F; Ohkubo Y; Mutoh S; Goto T
J Rheumatol; 2003 Oct; 30(10):2193-200. PubMed ID: 14528517
[TBL] [Abstract][Full Text] [Related]
11. Slow-release clodronate in prevention of inflammation and bone loss associated with adjuvant arthritis.
Osterman T; Virtamo T; Laurén L; Kippo K; Pasanen I; Hannuniemi R; Väänänen K; Sellman R
J Pharmacol Exp Ther; 1997 Feb; 280(2):1001-7. PubMed ID: 9023317
[TBL] [Abstract][Full Text] [Related]
12. Disease modifying effects of N-butyryl glucosamine in a streptococcal cell wall induced arthritis model in rats.
Wang SX; Cherian A; Dumitriu M; Grynpas MD; Carran J; Wainman D; Anastassiades T
J Rheumatol; 2007 Apr; 34(4):712-20. PubMed ID: 17309122
[TBL] [Abstract][Full Text] [Related]
13. Effects of a novel azaspirane (SK&F 105685) on arthritic lesions in the adjuvant Lewis rat: attenuation of the inflammatory process and preservation of skeletal integrity.
High WB; Bugelski PJ; Nichols ME; Swift BA; Solleveld HA; Badger AM
J Rheumatol; 1994 Mar; 21(3):476-83. PubMed ID: 8006892
[TBL] [Abstract][Full Text] [Related]
14. Anti-arthritic properties of FK506 on collagen-induced arthritis in rats.
Magari K; Nishigaki F; Sasakawa T; Ogawa T; Miyata S; Ohkubo Y; Mutoh S; Goto T
Inflamm Res; 2003 Dec; 52(12):524-9. PubMed ID: 14991082
[TBL] [Abstract][Full Text] [Related]
15. Additive bone-protective effects of anabolic treatment when used in conjunction with RANKL and tumor necrosis factor inhibition in two rat arthritis models.
Schett G; Middleton S; Bolon B; Stolina M; Brown H; Zhu L; Pretorius J; Zack DJ; Kostenuik P; Feige U
Arthritis Rheum; 2005 May; 52(5):1604-11. PubMed ID: 15880601
[TBL] [Abstract][Full Text] [Related]
16. Arthritic disease suppression and cartilage protection with glycosaminoglycan polypeptide complexes (Peptacans) derived from the cartilage extracellular matrix: a novel approach to therapy.
Ghosh P; Shimmon S; Whitehouse MW
Inflammopharmacology; 2006 Aug; 14(3-4):155-62. PubMed ID: 16983497
[TBL] [Abstract][Full Text] [Related]
17. Comparison of anti-arthritic properties of leflunomide with methotrexate and FK506: effect on T cell activation-induced inflammatory cytokine production in vitro and rat adjuvant-induced arthritis.
Magari K; Miyata S; Nishigaki F; Ohkubo Y; Mutoh S
Inflamm Res; 2004 Oct; 53(10):544-50. PubMed ID: 15597149
[TBL] [Abstract][Full Text] [Related]
18. Antiinflammatory and analgesic effects of somatostatin released from capsaicin-sensitive sensory nerve terminals in a Freund's adjuvant-induced chronic arthritis model in the rat.
Helyes Z; Szabó A; Németh J; Jakab B; Pintér E; Bánvölgyi A; Kereskai L; Kéri G; Szolcsányi J
Arthritis Rheum; 2004 May; 50(5):1677-85. PubMed ID: 15146439
[TBL] [Abstract][Full Text] [Related]
19. Osteoprotegerin reduces the loss of periarticular bone mass in primary and secondary spongiosa but does not influence inflammation in rat antigen-induced arthritis.
Neumann T; Oelzner P; Petrow PK; Thoss K; Hein G; Stein G; Bräuer R
Inflamm Res; 2006 Jan; 55(1):32-9. PubMed ID: 16429254
[TBL] [Abstract][Full Text] [Related]
20. Spinal adenosine receptor activation inhibits inflammation and joint destruction in rat adjuvant-induced arthritis.
Boyle DL; Moore J; Yang L; Sorkin LS; Firestein GS
Arthritis Rheum; 2002 Nov; 46(11):3076-82. PubMed ID: 12428252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
